Stock Trading

By Jake KingIt doesn't get much better than this, and Synergy Pharmaceuticals (SGYP) remains a favorite PropThink idea. The company's lead drug candidate, plecanatide, has demonstrated strong safety and efficacy results in a 951-patient ...
By Jake KingIt doesn't get much better than this, and Synergy Pharmaceuticals (SGYP) remains a favorite PropThink idea. The company's lead drug candidate, plecanatide, has demonstrated strong safety and efficacy results in a 951-patient clinical trial, there's a path to FDA approval, and the company is trading at a fraction of the value of its closest competitor, Ironwood Pharmaceuticals (IRWD). Once approved, plecanatide will likely have a number of commercial advantages over Ironwood's Linzess (linaclotide): specifically, much lower rates of diarrhea, a prohibitive side effect. While Linzess has beaten plecanatide to the market by about three years, Ironwood and partner Forest Labs (FRX) will do all of the heavy lifting, spending significant marketing and promotional resources to penetrate the market. Both Linzess and plecanatide are guanylate cyclase-C (GC-C) agonists, the only two drugs in a new class of compounds for the treatment of chronic idiopathic constipation (CIC)
16 minutes ago
Stocks should do well when the economy does well. This seems like a no brainer. After all, a strong economy should mean that more profit and growth is available to corporations, and that should make its way down to shareholders. This, in...
Stocks should do well when the economy does well. This seems like a no brainer. After all, a strong economy should mean that more profit and growth is available to corporations, and that should make its way down to shareholders. This, in turn, should reward investors who pursue broad market exposures offered through ETFs like SPDR S&P 500 (SPY), and Vanguard Total Stock Market (VTI) and others.But does it really work this way, and is GDP growth predictive of future stock returns? To answer this question, we compared both calendar year and quarterly changes in real GDP to changes in the S&P 500 Total Return Index.First, using calendar year data from 1930-2012, we ran correlation and regression analysis on the S&P 500 Total Return Index lagged one year behind real GDP in the U.S. In other words, we asked the question "Does the change in real GDP
16 minutes ago
Perseus Mining (PMNXF.PK) is an up-and-coming mid-tier gold mining company with a focus on Western Africa. During 2012 Perseus brought the Edikan mine in Ghana into commercial production resulting in an output of 195,166 ounces of gold f...
Perseus Mining (PMNXF.PK) is an up-and-coming mid-tier gold mining company with a focus on Western Africa. During 2012 Perseus brought the Edikan mine in Ghana into commercial production resulting in an output of 195,166 ounces of gold for the calendar year. The company is presently working towards production at their second mine in Cote D'Ivoire by Q1/2014. Additionally, the company has exploration projects in the mentioned jurisdictions and also in Mali and Guinea. The market capitalization has been reduced to $463M in the wake of the drop in gold spot price and at $1.01 the share price is only a quarter of its high point late in 2011. The forward P/E is given as 5.4 on Morningstar.com. The table below gives the 2012 numbers for production, reserves and resources at Perseus' mine and projects. (click to enlarge) The term "country risk" is often associated with factors such
18 minutes ago
SEMAFO (SEMFF.PK) is a Canada-based mining company with gold production and exploration activities in West Africa. The company currently operates three gold mines: the flagship Mana Mine in Burkina Faso, the Samira Hill Mine in Niger and...
SEMAFO (SEMFF.PK) is a Canada-based mining company with gold production and exploration activities in West Africa. The company currently operates three gold mines: the flagship Mana Mine in Burkina Faso, the Samira Hill Mine in Niger and the Kiniero Mine in Guinea producing 236,000 ounces of gold in 2012. SEMAFO has a market capitalization of $389M and according to Morningstar.com the forward P/E is 6.4. From the heights of $13 at the start of 2011 the share price has dropped to $1.60 at the time of writing. The table below gives the 2012 numbers for attributable production, reserves and resources at SEMAFO's mines. (click to enlarge) Factors such as political risk, exchange rate risk, economic risk, sovereign risk, transfer risk, socio-economic risk and others are included in most definitions of country risk. In a series of recent articles we collated country risk ratings for numerous countries from
19 minutes ago
In recent years, the “growth vs. austerity” debate has been raging in academic and policy circles. In recent weeks the growth crowd have been claiming victory, citing: Research showing Carmen Reinhart and Kenneth Rogoff’s seminal work on...
In recent years, the “growth vs. austerity” debate has been raging in academic and policy circles. In recent weeks the growth crowd have been claiming victory, citing: Research showing Carmen Reinhart and Kenneth Rogoff’s seminal work on debt-to-GDP levels contained numerous errors and was not so conclusive as originally believed. (Related: Did Harvard Economists Make [...]
20 minutes ago
Sarepta Therapeutics Inc. (SRPT) 2013 UBS Global Healthcare Conference Call May 21, 2013 8:30 AM ET Executives Chris Garabedian – President and CEO Presentation Matthew Harrison Thanks for coming in the second of the UBS Gl...
Sarepta Therapeutics Inc. (SRPT) 2013 UBS Global Healthcare Conference Call May 21, 2013 8:30 AM ET Executives Chris Garabedian – President and CEO Presentation Matthew Harrison Thanks for coming in the second of the UBS Global Healthcare Conference. I’m Matthew Harrison, one of the biotech analysts here, and pleased to have Sarepta presenting this morning. We have the CEO, Chris Garabedian presenting and happy to introduce him. Chris? Chris Garabedian Thanks, Matt, and thanks to UBS for the invitation to present today. Yeah, I’d like to present on Sarepta therapeutics and what our Company is working on particularly in the DMD space. I’ll be making some forward-looking statements, so please refer to our SEC filings for risk factors associated with the Company. We’re building a company that is designed for independence and success in the future. And we’re assembling a team that really understands drug development, regulatory, and manufacturing and
20 minutes ago
Best Buy (NYSE: BBY) reported this morning; here's the short version: THE CONTEXT: Its adjusted earnings beat Wall Street expectations, but revenue fell short as the company faced tough pricing competition during the quarter. The co...
Best Buy (NYSE: BBY) reported this morning; here's the short version: THE CONTEXT: Its adjusted earnings beat Wall Street expectations, but revenue fell short as the company faced tough pricing competition during the quarter. The company has been working on a turnaround plan as it faces increased competition from online retailers and discount stores. Uh, revenues fell short? Remember, the issue is that the firm extended its "price match" guarantee against online retailers (read: Amazon) in the quarter. Revenue was off 10%, which shouldn't be happening if the company's price-match was actually doing what it expects, which is to entice people to buy locally rather than over the Internet. This strongly implies that either it is not really price-matching in a form and fashion that consumers are willing to deal with or the stores suck, the retail experience sucks, and thus the customers are buying online
24 minutes ago
In February, I warned investors of the apparent overvaluation of Diana Containerships (DCIX), and followed up with a more in-depth look at their business model in March. My primary message was that the dividend was not sustainable, the b...
In February, I warned investors of the apparent overvaluation of Diana Containerships (DCIX), and followed up with a more in-depth look at their business model in March. My primary message was that the dividend was not sustainable, the business model would ultimately destroy value, and a secondary offering was on the way. This article will offer commentary on the Q1-13 results, discuss a recent business model change, and provide target dates for interested investors. I recommend a strong sell based on a broken business model with limited real dividend sustainability. Reflection on Targets My first article was published when DCIX was $7, and the second article still recommended a sell at $5.95. Including dividends DCIX has lost 13.6% and gained 0% (based on current price of $5.95) versus S&P 500 increases of 11.2% and 8.1%, for a total relative gain on my call of 24.8% and 8.1% in
24 minutes ago
On Tuesday morning, Apple (NASDAQ:AAPL) Chief Executive Officer Tim Cook appeared before the Senate Permanent Subcommittee on Investigations regarding what The New York Times‘ iEconomy series termed the “extraordinary lengths” the ...
On Tuesday morning, Apple (NASDAQ:AAPL) Chief Executive Officer Tim Cook appeared before the Senate Permanent Subcommittee on Investigations regarding what The New York Times‘ iEconomy series termed the “extraordinary lengths” the iPhone maker has taken to avoid paying its fair share of taxes, efforts that have gone well beyond the tax reduction strategies U.S. corporations typically utilize. In particular, the focus of the Senate’s probe centered on Apple’s operations in Ireland. Is Apple now a once-in-a-decade buying opportunity? Click here to get your 24-page Ultimate Cheat Sheet to Apple’s Stock now! A 40-page memorandum released ahead of Cook’s appearance before Congress identified three subsidiaries that have no tax residency in Ireland, where they are incorporated, or in the United States, where the companies are managed. Apple’s arrangement with the country enables it to pay just 1.9 percent tax on its $37 billion in overseas profits even though the average tax rate in the countries of the Organisation for Economic Co-operation and Development was 24 percent in 2012. Many U.S. companies have taken advantage of Ireland’s tax regime to minimize their tax burdens, including Google (NASDAQ:GOOG), Microsoft (NASDAQ:MSFT), and Facebook (NASDAQ:FB). The report said, “Ireland has essentially functioned as a tax haven for Apple.” The company’s main subsidiary — Apple Operations International, a holding company that includes Apple’s retail stores in Europe — did not pay any corporate income tax in the last five years, according to the document. In its 17-page testimony submitted on Monday, Apple argued: Apple, a California company, employs tens of thousands of Americans, creates revolutionary products that improve the lives of tens of millions of Americans, and pays billions of dollars annually to the U.S. Treasury in corporate income and payroll taxes. Apple’s shareholders – from individuals and institutions to pension funds and public employee retirement systems – have benefitted from the Company’s success through the appreciation of its stock price and generous dividends. Apple safeguards the capital entrusted to it by its shareholders with prudent management that reflects the Company’s extensive international operations. Apple complies fully with both the laws and spirit of the laws. And Apple pays all its required taxes, both in this country and abroad. NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW! As Cook asserted in the opening moments of his testimony, Apple paid a corporate tax rate of 30.5 percent in 2012, which resulted in a bill of $6 billion of the past fiscal year. The iPhone maker was not brought before the Senate subcommittee because it has violated the law, but because an analysis of the company’s current practices will serve to further the legislative body’s attempt to draft new tax codes. Apple’s testimony had three stages. The easy part was the recitation of how much the company pays in federal taxes. The short part was the delivery of its four recommendations for simplifying U.S. tax codes. Cook, noting that Apple favors simplicity over complexity, said Congress should make the following adjustments to the tax code: be revenue neutral, eliminate corporate loopholes, lower corporate tax rates, and implement a “reasonable tax” on foreign earnings that would allow the company to spend some of its oversea funds. The hard part for Apple was explaining its operations in Ireland. Opening the hearing, Democratic Senator Carl Levin of Michigan, who chairs the subcommittee on investigations, noted that Apple has a complex system of tax avoidance. He then repeated a statement made on Monday that claimed Apple has sought the “Holy Grail” of tax avoidance by setting up companies without workers in countries such as Ireland. Later, Republican Senator John McCain of Arizona, noting that the U.S. corporate tax
26 minutes ago
LinkedIn (NYSE:LNKD): BGC Partners has initiated coverage of LinkedIn with a Buy, stating that it sees LinkedIn as an innovative, well-managed company that is just starting to disrupt large markets. The price target on the shares is set ...
LinkedIn (NYSE:LNKD): BGC Partners has initiated coverage of LinkedIn with a Buy, stating that it sees LinkedIn as an innovative, well-managed company that is just starting to disrupt large markets. The price target on the shares is set for $225. NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW! GameStop (NYSE:GME): Sterne Agee has raised the price target on Gamestop from $35 to $46, as the firm thinks that the company can generate significantly higher than expected earnings in the next few years. It keeps a Buy rating on the shares. NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW! Priceline.com (NASDAQ:PCLN): Cantor has lifted its price target on the company to better reflect its acquisition of Kayak.com, effective on Tuesday. The firm remains upbeat on the company, and keeps a Buy rating on the stock. NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW! Yahoo (NASDAQ:YHOO): Citing a higher valuation for Alibaba, and Yahoo’s acquisition of Tumblr, Oppenheimer has raised its price target to $30 from $27, as it believes that the Tumblr deal is an attempt by Yahoo to strengthen its mobile and social capabilities, while adding more younger users to its platform. The firm keeps an Outperform rating on Yahoo shares. NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW! Investing Insights: Will Baidu’s Momentum Continue? Read the original article from Wall St. Cheat Sheet
26 minutes ago